<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04860401</url>
  </required_header>
  <id_info>
    <org_study_id>PB_2016-00395</org_study_id>
    <nct_id>NCT04860401</nct_id>
  </id_info>
  <brief_title>OxyPrem Validation Study</brief_title>
  <official_title>A Miniaturized Device to Non-invasively Measure the Oxygenation and Hemoglobin Concentration in the Brain Using Near-infrared Spectroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hans Ulrich Bucher</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The precision of the novel diagnostic near-infrared spectroscopy (NIRS) device for the&#xD;
      measurement of tissue oxygenation and hemoglobin concentration (OxyPrem) is assessed by&#xD;
      repeated measurements. The accuracy of OxyPrem is assessed by comparing the measurement data&#xD;
      to those acquired simultaneously by established NIRS devices and standard clinical monitoring&#xD;
      devices. In substudy 1, healthy adult subjects are enrolled, in substudy 2, measurements are&#xD;
      conducted on preterm neonates.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 4, 2010</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Other</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Standard deviation of repeated StO2 level measurements (precision)</measure>
    <time_frame>baseline</time_frame>
    <description>The precision of the StO2 measurement is the reproducibility within multiple consecutive measurements under similar conditions, expressed as the standard deviation of repeated measurements.</description>
  </primary_outcome>
  <enrollment type="Anticipated">145</enrollment>
  <condition>Tissue Oxygenation Measurement</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Measurement of tissue oxygenation with novel diagnostic near-infrared spectroscopy device (OxyPrem) (no clinical decisions based on oxygenation levels)</intervention_name>
    <description>The precision of OxyPrem is assessed by repeated measurements of tissue oxygenation and hemoglobin concentration. The accuracy of OxyPrem is assessed by comparing the measurement data to those acquired simultaneously by established NIRS devices and standard clinical monitoring devices. In substudy 1, healthy adult subjects are enrolled, in substudy 2, measurements are conducted on preterm neonates.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Substudy 1 (healthy adult volunteers)&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy adult&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dense black hair at the location of measurement&#xD;
&#xD;
          -  Neurological diseases.&#xD;
&#xD;
        Substudy 2 (preterm infants)&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Pre-term neonates (gestational age at birth less than 37 weeks)&#xD;
&#xD;
          -  Signed informed consent by at least one parent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinically instability&#xD;
&#xD;
          -  Malformations&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bucher, Prof.em.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bucher, Prof.em.</last_name>
    <phone>+41 78 703 78 35</phone>
    <email>buh@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Zurich</name>
      <address>
        <city>ZÃ¼rich</city>
        <state>Zurich</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bucher, Prof.em.</last_name>
      <phone>044 255 53 40</phone>
      <email>buh@usz.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 15, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2021</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Hans Ulrich Bucher</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

